On the origin of great ideas: Science in the age of big pharma

Hastings Center Report

Volumn 35, Issue 6, 2005, Pages 17-19

  Mchenry, Leemon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 28644438445     PISSN: 00930334     EISSN: None     Source Type: Journal    
DOI: 10.2307/3528561     Document Type: Short Survey

References (14)

1. These documents can be viewed at http://abcnews.go.com/Health/story?id= 311956&page=1.
2. 6th World Congress of Biological Psychiatry, "Interruption or Discontinuation of Antidepressant Therapy: A Critical Consideration in Patient Management," Nice, France, 1997,
3. and "SSRI Discontinuation Events," Phoenix, Arizona, 1996.
4. J.F. Rosenbaum and J. Zajecka, "Clincal Management of Antidepressant Discontinuation," Journal of Clinical Psychiatry 58 (suppl. 7) (1997), 37-40.
5. J.F. Rosenbaum and J. Zajecka, " Journal of Clinical Psychiatry Ibid., 39.
6. SmithKline Beecham Business Plan Guide, Sales Cycle 2, 1997, December 1, 1997-May 31, 1998, 0290-0297.
7. SmithKline Beecham Business Plan Guide, Ibid., 0264.
8. Sandra Stahl, Ruder-Finn memo, June 5, 1997, 0260.
9. Journal of Clinical Psychiatry 59, no. 10, October 1998, 535-36.
10. SmithKline Beecham Business Plan Guide, 0297.
11. SmithKline Beecham Business Plan Guide, Ibid., 0296.
12. House of Commons Health Committee, The Influence of the Pharmaceutical Industry, Fourth Report of Session 2004-05, volume I, March 22, 2005, 54.
13. Email correspondence from Meg M. Waters, Director of Editorial Services, Physicians Postgraduate Press, April 7, 2005. See "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication," at www.icmje.org/#conflicts.
14. See http://abcnews.go.com/images/Primetime/paxil_moneybag. pdf.